By Regulatory Approvals — Replimune finally wins approval, Q2 earnings wrap up, psychedelics stay in spotlight BioSpace
Read the original at Regulatory Approvals ↗
Auto-published by the finit.news Events monitor from Regulatory Approvals; summarized by AI and may contain errors — verify against the primary source. August 12, 2026.